US Stock MarketDetailed Quotes

Cytosorbents (CTSO)

Watchlist

0.5706
-0.0153-2.61%

Close May 13 16:00 ET

35.83MMarket Cap-3.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytosorbents (CTSO) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

66.47%-1.16M

14.22%-12.38M

-106.11%-4.83M

-4.63%-2.58M

68.52%-1.51M

28.24%-3.47M

33.37%-14.43M

63.46%-2.34M

52.69%-2.46M

30.85%-4.79M

Net income from continuing operations

-246.79%-5.13M

60.43%-8.2M

27.36%-5.5M

-14.52%-3.17M

145.35%1.95M

75.71%-1.48M

29.16%-20.72M

-15.10%-7.57M

69.89%-2.77M

30.19%-4.3M

Operating gains losses

140.74%1.23M

-320.62%-9.32M

-103.93%-193K

102.42%64K

-1,235.01%-6.18M

-311.41%-3.01M

316.75%4.23M

282.80%4.91M

-246.44%-2.65M

231.17%544.31K

Depreciation and amortization

-7.16%376K

-6.48%1.63M

-9.41%385K

-6.53%401K

-1.52%440K

-8.62%405K

-13.81%1.74M

-46.16%425K

-7.27%429K

-2.32%446.79K

Other non cash items

53.16%291K

66.67%820K

30.37%249K

0.00%190K

90.45%191K

1,673.55%190K

1,048.00%492K

1,682.71%191K

1,673.38%190K

835.95%100.29K

Change In working capital

416.92%1.26M

76.48%-1.03M

6.35%-1.17M

-156.29%-734K

145.74%1.27M

76.34%-396K

-265.30%-4.38M

-443.27%-1.24M

677.41%1.3M

-124.65%-2.77M

-Change in receivables

487.50%310K

124.59%423K

87.44%-137K

-77.10%303K

130.53%337K

90.57%-80K

-600.28%-1.72M

-405.03%-1.09M

97.93%1.32M

23.83%-1.1M

-Change in inventory

463.32%723K

-608.00%-2.54M

-472.62%-1.29M

-127.22%-322K

-20.97%-726K

53.71%-199K

172.82%500K

220.26%347K

220.95%1.18M

-101.89%-600.13K

-Change in prepaid assets

-48.40%129K

232.47%1.79M

143.19%802K

-1,215.94%-908K

627.45%1.65M

-71.79%250K

-222.45%-1.35M

-597.22%-1.86M

75.29%-69K

-136.56%-312.26K

-Change in payables and accrued expense

125.07%92K

60.95%-706K

-139.69%-539K

117.02%193K

100.93%7K

71.37%-367K

-212.48%-1.81M

142.64%1.36M

-249.87%-1.13M

-121.44%-750.28K

-Change in other current assets

--1K

100.00%2K

300.00%2K

--0

2,140.82%1K

-1,940.82%-1K

--1K

----

Cash from discontinued investing activities

Operating cash flow

66.47%-1.16M

14.22%-12.38M

-106.11%-4.83M

-4.63%-2.58M

68.52%-1.51M

28.24%-3.47M

33.37%-14.43M

63.46%-2.34M

52.69%-2.46M

30.85%-4.79M

Investing cash flow

Cash flow from continuing investing activities

2.13%-46K

37.97%-415K

-134.68%-291K

118.39%55K

-10.94%-132K

63.00%-47K

28.54%-669K

8.77%-124K

-16.02%-299K

-184.81%-118.98K

Net PPE purchase and sale

850.00%15K

69.01%-88K

53.62%-32K

88.82%-17K

-107.76%-37K

95.57%-2K

47.22%-284K

27.75%-69K

-6.74%-152K

-108.50%-17.81K

Net intangibles purchase and sale

-35.56%-61K

15.06%-327K

-370.91%-259K

148.98%72K

6.10%-95K

45.01%-45K

3.30%-385K

-36.05%-55K

-27.47%-147K

-46.28%-101.17K

Cash from discontinued investing activities

Investing cash flow

2.13%-46K

37.97%-415K

-134.68%-291K

118.39%55K

-10.94%-132K

63.00%-47K

28.54%-669K

8.77%-124K

-16.02%-299K

-184.81%-118.98K

Financing cash flow

Cash flow from continuing financing activities

-0.24%9.31M

1,383.83%2.48M

1,294.73%6.83M

-35.53%9.33M

-98.63%167K

-115.27%-99K

956.23%9.83M

Net issuance payments of debt

----

-75.22%2.48M

--2.48M

--0

--10M

--0

--10.63M

Net common stock issuance

--0

2,912.29%5.39M

--0

--5.39M

-98.74%179K

-98.63%167K

-106.48%-41K

-93.17%53K

Proceeds from stock option exercised by employees

--0

--1.44M

--0

2,602.96%1.44M

--0

-134.39%-53.24K

Net other financing activities

----

---848K

--0

---58K

----

Cash from discontinued financing activities

Financing cash flow

--0

-0.24%9.31M

1,383.83%2.48M

--0

1,294.73%6.83M

-35.53%9.33M

-98.63%167K

-115.27%-99K

956.23%9.83M

Net cash flow

Beginning cash position

-20.41%7.77M

-37.47%9.76M

-25.56%9.06M

-21.53%11.73M

29.90%13.11M

-37.47%9.76M

-34.48%15.62M

21.12%12.17M

0.71%14.94M

-51.33%10.09M

Current changes in cash

-136.41%-1.21M

39.59%-3.48M

-14.80%-2.64M

11.85%-2.52M

-133.34%-1.64M

160.02%3.32M

28.97%-5.77M

-140.55%-2.3M

40.59%-2.86M

183.96%4.92M

Effect of exchange rate changes

-914.29%-228K

1,852.94%1.49M

1,374.53%1.35M

-271.76%-146K

468.29%257K

384.26%28K

14.80%-85K

-7.54%-106K

267.28%85K

-99.36%-69.78K

End cash Position

-51.68%6.34M

-20.41%7.77M

-25.56%9.06M

-21.53%11.73M

29.90%13.11M

-37.47%9.76M

21.12%12.17M

0.71%14.94M

Free cash flow

64.87%-1.23M

14.76%-12.87M

-110.63%-5.19M

8.69%-2.52M

66.60%-1.64M

29.13%-3.51M

33.17%-15.1M

62.33%-2.47M

49.45%-2.76M

27.67%-4.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	66.47%-1.16M	14.22%-12.38M	-106.11%-4.83M	-4.63%-2.58M	68.52%-1.51M	28.24%-3.47M	33.37%-14.43M	63.46%-2.34M	52.69%-2.46M	30.85%-4.79M
Net income from continuing operations	-246.79%-5.13M	60.43%-8.2M	27.36%-5.5M	-14.52%-3.17M	145.35%1.95M	75.71%-1.48M	29.16%-20.72M	-15.10%-7.57M	69.89%-2.77M	30.19%-4.3M
Operating gains losses	140.74%1.23M	-320.62%-9.32M	-103.93%-193K	102.42%64K	-1,235.01%-6.18M	-311.41%-3.01M	316.75%4.23M	282.80%4.91M	-246.44%-2.65M	231.17%544.31K
Depreciation and amortization	-7.16%376K	-6.48%1.63M	-9.41%385K	-6.53%401K	-1.52%440K	-8.62%405K	-13.81%1.74M	-46.16%425K	-7.27%429K	-2.32%446.79K
Other non cash items	53.16%291K	66.67%820K	30.37%249K	0.00%190K	90.45%191K	1,673.55%190K	1,048.00%492K	1,682.71%191K	1,673.38%190K	835.95%100.29K
Change In working capital	416.92%1.26M	76.48%-1.03M	6.35%-1.17M	-156.29%-734K	145.74%1.27M	76.34%-396K	-265.30%-4.38M	-443.27%-1.24M	677.41%1.3M	-124.65%-2.77M
-Change in receivables	487.50%310K	124.59%423K	87.44%-137K	-77.10%303K	130.53%337K	90.57%-80K	-600.28%-1.72M	-405.03%-1.09M	97.93%1.32M	23.83%-1.1M
-Change in inventory	463.32%723K	-608.00%-2.54M	-472.62%-1.29M	-127.22%-322K	-20.97%-726K	53.71%-199K	172.82%500K	220.26%347K	220.95%1.18M	-101.89%-600.13K
-Change in prepaid assets	-48.40%129K	232.47%1.79M	143.19%802K	-1,215.94%-908K	627.45%1.65M	-71.79%250K	-222.45%-1.35M	-597.22%-1.86M	75.29%-69K	-136.56%-312.26K
-Change in payables and accrued expense	125.07%92K	60.95%-706K	-139.69%-539K	117.02%193K	100.93%7K	71.37%-367K	-212.48%-1.81M	142.64%1.36M	-249.87%-1.13M	-121.44%-750.28K
-Change in other current assets	--1K	100.00%2K	300.00%2K	--0	--0	--0	2,140.82%1K	-1,940.82%-1K	--1K	----
Cash from discontinued investing activities
Operating cash flow	66.47%-1.16M	14.22%-12.38M	-106.11%-4.83M	-4.63%-2.58M	68.52%-1.51M	28.24%-3.47M	33.37%-14.43M	63.46%-2.34M	52.69%-2.46M	30.85%-4.79M
Investing cash flow
Cash flow from continuing investing activities	2.13%-46K	37.97%-415K	-134.68%-291K	118.39%55K	-10.94%-132K	63.00%-47K	28.54%-669K	8.77%-124K	-16.02%-299K	-184.81%-118.98K
Net PPE purchase and sale	850.00%15K	69.01%-88K	53.62%-32K	88.82%-17K	-107.76%-37K	95.57%-2K	47.22%-284K	27.75%-69K	-6.74%-152K	-108.50%-17.81K
Net intangibles purchase and sale	-35.56%-61K	15.06%-327K	-370.91%-259K	148.98%72K	6.10%-95K	45.01%-45K	3.30%-385K	-36.05%-55K	-27.47%-147K	-46.28%-101.17K
Cash from discontinued investing activities
Investing cash flow	2.13%-46K	37.97%-415K	-134.68%-291K	118.39%55K	-10.94%-132K	63.00%-47K	28.54%-669K	8.77%-124K	-16.02%-299K	-184.81%-118.98K
Financing cash flow
Cash flow from continuing financing activities	0	-0.24%9.31M	1,383.83%2.48M	0	0	1,294.73%6.83M	-35.53%9.33M	-98.63%167K	-115.27%-99K	956.23%9.83M
Net issuance payments of debt	----	-75.22%2.48M	--2.48M	--0	--0	--0	--10M	--0	--0	--10.63M
Net common stock issuance	--0	2,912.29%5.39M	--0	--0	--0	--5.39M	-98.74%179K	-98.63%167K	-106.48%-41K	-93.17%53K
Proceeds from stock option exercised by employees	--0	--1.44M	--0	--0	--0	2,602.96%1.44M	--0	--0	--0	-134.39%-53.24K
Net other financing activities	----	----	----	----	----	----	---848K	--0	---58K	----
Cash from discontinued financing activities
Financing cash flow	--0	-0.24%9.31M	1,383.83%2.48M	--0	--0	1,294.73%6.83M	-35.53%9.33M	-98.63%167K	-115.27%-99K	956.23%9.83M
Net cash flow
Beginning cash position	-20.41%7.77M	-37.47%9.76M	-25.56%9.06M	-21.53%11.73M	29.90%13.11M	-37.47%9.76M	-34.48%15.62M	21.12%12.17M	0.71%14.94M	-51.33%10.09M
Current changes in cash	-136.41%-1.21M	39.59%-3.48M	-14.80%-2.64M	11.85%-2.52M	-133.34%-1.64M	160.02%3.32M	28.97%-5.77M	-140.55%-2.3M	40.59%-2.86M	183.96%4.92M
Effect of exchange rate changes	-914.29%-228K	1,852.94%1.49M	1,374.53%1.35M	-271.76%-146K	468.29%257K	384.26%28K	14.80%-85K	-7.54%-106K	267.28%85K	-99.36%-69.78K
End cash Position	-51.68%6.34M	-20.41%7.77M	-20.41%7.77M	-25.56%9.06M	-21.53%11.73M	29.90%13.11M	-37.47%9.76M	-37.47%9.76M	21.12%12.17M	0.71%14.94M
Free cash flow	64.87%-1.23M	14.76%-12.87M	-110.63%-5.19M	8.69%-2.52M	66.60%-1.64M	29.13%-3.51M	33.17%-15.1M	62.33%-2.47M	49.45%-2.76M	27.67%-4.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm